1. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
- Author
-
Wester JP, Haas FJ, Biesma DH, Leusink JA, and Veth G
- Subjects
- Adult, Aged, Aged, 80 and over, Anticoagulants therapeutic use, Case-Control Studies, Chondroitin Sulfates therapeutic use, Dermatan Sulfate therapeutic use, Drug Combinations, Female, Heparitin Sulfate therapeutic use, Humans, Incidence, Intensive Care Units, Male, Middle Aged, Multiple Organ Failure complications, Risk Factors, Thrombocytopenia complications, Anticoagulants adverse effects, Critical Illness, Hemorrhage chemically induced, Heparin adverse effects, Thrombocytopenia chemically induced, Venous Thrombosis chemically induced
- Abstract
Objective: Heparin-induced thrombocytopenia (HIT) is the most common form of drug-induced immune-mediated thrombocytopenia. HIT may be aggravated by life-threatening arterial and venous thrombosis and, to a lesser extent, hemorrhagic complications. We investigated the incidence of thromboembolic and hemorrhagic complications in critically ill patients with the multiple organ dysfunction syndrome and HIT., Design: Case-control study., Setting: A 33-bed general intensive care unit in a university-affiliated teaching hospital., Patients: Twenty consecutive patients with laboratory-proven HIT compared with 20 contemporary, consecutive patients without HIT., Interventions: Unfractionated heparin or low-molecular-weight heparin were replaced by danaparoid sodium in patients with HIT., Measurements and Results: Heparin-induced thrombocytopenia was proven by a positive platelet aggregation test. The HIT group consisted of 14 males and 6 females aged 65.2+/-10.8 years (mean +/- standard deviation) with APACHE II scores of 26.7+/-5.4. Thrombocytopenia less than 100 x 10(9)/l developed within 6.4+/-7.0 days. In 12 patients thrombocytopenia resolved after discontinuation of unfractionated heparin in 8.8+/-6.4 days. Arterial and venous thromboembolic complications occurred more frequently in HIT patients than in non-HIT patients (10/20 (50%) versus 0/20 (0%); chi-square p<0.001). Hemorrhagic complications also occurred more frequently in HIT patients than in non-HIT patients (17/20 (85%) versus 7/20 (35%); chi-square p=0.001)., Conclusion: In critically ill patients with HIT, the incidence of thromboembolic complications and hemorrhagic complications was remarkably high.
- Published
- 2004
- Full Text
- View/download PDF